Literature DB >> 1727860

Paramyosin inhibits complement C1.

J P Laclette1, C B Shoemaker, D Richter, L Arcos, N Pante, C Cohen, D Bing, A Nicholson-Weller.   

Abstract

We report here the results of studies showing that inhibition of C is a property of several invertebrate paramyosins. Paramyosins from Taenia solium, Schistosoma mansoni, and the mussel Mytilus edulis bind polymeric collagen and can be isolated from crude extracts of tissues by collagen affinity. These paramyosins inhibit C1 function whether the C1 is isolated or present in C2-deficient serum. Because T. solium paramyosin was the best inhibitor, we concentrated further studies on this molecule. T. solium paramyosin binds purified C1q in solution with a dose/response similar to C1r2S2. Further studies of the C1-paramyosin interaction indicate that: 1) C4 is not activated, 2) C4b2a decay is not affected, and 3) there is no effect on the efficiency of C3-9, as provided in EDTA-chelated guinea pig serum, in lysing SRBC. Thus, paramyosin inhibition is directed at the initiation of the classical pathway. The results suggest that paramyosins of helminthic parasites may have a role as modulators of the host immune response through C inhibition at C1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1727860

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

Review 1.  The immune response to parasitic helminths of veterinary importance and its potential manipulation for future vaccine control strategies.

Authors:  Neil Foster; Hany M Elsheikha
Journal:  Parasitol Res       Date:  2012-05       Impact factor: 2.289

2.  The implantation of Taenia solium metacestodes in mice induces down-modulation of T-cell proliferation and cytokine production.

Authors:  Lilian Hernández-Mendoza; José Luis Molinari; Esperanza Garrido; Isabel Cortés; Sandra Solano; Enrique Miranda; Patricia Tato
Journal:  Parasitol Res       Date:  2005-01-28       Impact factor: 2.289

3.  Control of scavenger receptor-mediated endocytosis by novel ligands of different length.

Authors:  Margarita Guaderrama-Díaz; Carlos F Solís; Gabriela Velasco-Loyden; Juan P Laclette; Jaime Mas-Oliva
Journal:  Mol Cell Biochem       Date:  2005-03       Impact factor: 3.396

4.  Granuloma cytokines in murine cysticercosis.

Authors:  P Robinson; R L Atmar; D E Lewis; A C White
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

5.  Rapid appearance and asymmetric distribution of glucose transporter SGTP4 at the apical surface of intramammalian-stage Schistosoma mansoni.

Authors:  P J Skelly; C B Shoemaker
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

6.  Paramyosin of Echinococcus granulosus: cDNA sequence and characterization of a tegumental antigen.

Authors:  F Mühlschlegel; L Sygulla; P Frosch; P Massetti; M Frosch
Journal:  Parasitol Res       Date:  1993       Impact factor: 2.289

7.  A novel nuclear marker, Pm-int9, for phylogenetic studies of Opisthorchis felineus, Opisthorchis viverrini, and Clonorchis sinensis (Opisthorchiidae, Trematoda).

Authors:  Sergei V Shekhovtsov; Alexei V Katokhin; Konstantin V Romanov; Vladimir V Besprozvannykh; Konstantin P Fedorov; Natalia I Yurlova; Elena A Serbina; Paiboon Sithithaworn; Nikolai A Kolchanov; Viatcheslav A Mordvinov
Journal:  Parasitol Res       Date:  2009-09-24       Impact factor: 2.289

8.  Molecular cloning and characterization of a paramyosin from Clonorchis sinensis.

Authors:  Tae-Joon Park; Jung-Mi Kang; Byoung-Kuk Na; Woon-Mok Sohn
Journal:  Korean J Parasitol       Date:  2009-12-01       Impact factor: 1.341

9.  A cysteine protease from Taenia solium metacestodes induce apoptosis in human CD4+ T-cells.

Authors:  P Tato; A M Fernández; S Solano; V Borgonio; E Garrido; J Sepúlveda; J L Molinari
Journal:  Parasitol Res       Date:  2003-12-03       Impact factor: 2.289

10.  Inhibition of the complement membrane attack complex by Schistosoma mansoni paramyosin.

Authors:  Jiusheng Deng; Daniel Gold; Philip T LoVerde; Zvi Fishelson
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.